PAVmed is a medical technology company organized to advance a pipeline of medical technologies from concept to commercialization. Co.'s EsoGuard and EsoCheck have been developed to provide a screening test for the early detection of adenocarcinoma of the esophagus (EAC) and Barrett's Esophagus (BE), including dysplastic BE and related pre-cursors to EAC in patients with chronic gastroesophageal reflux. Co.'s EsoCure is in development as an Esophageal Ablation Device, with the intent to allow a clinician to treat dysplastic BE before it can progress to EAC, a lethal esophageal cancer. Co.'s CarpX is a minimally invasive surgical device for use in the treatment of carpal tunnel syndrome.